(Compiled by Peter Viksveen, European Network for Homeopathy Research ENHR. For information, please refer to www.homeopathy-ecch.eu and outside Europe, www.homeopathy-ich.org)
Hayfever, asthma, and perennial rhinitis
Reilly and colleagues have conducted a series of trials in patients with hayfever, asthma and perennial rhinitis. Patients were given skin tests and remedies were chosen on the basis of reactivity. This design allows individualisation whilst avoiding the issues of case-taking and the effect that this has on the process. The results demonstrate a significant difference between the placebo and homeopathic groups which is reproducible. Strictly speaking these are trials of isopathy.
Reilly’s challenge (editorial). Lancet 1994; 344: 1585.
Reilly DT, Taylor MA. Potent placebo of potency? A proposed study model with initial findings using homoeopathically prepared pollens in hay fever as a model. British Homoeopathic Journal 1985 ; 74: 65-75.
Reilly DT, Taylor MA, Campbell J, Beattie N, McSharry C, Aitchison T, Carter R, Stevenson R. Is evidence for homoeopathy reproducible? Lancet 1994; 334: 1601-1606.
Reilly DT, Taylor MA, McSharry C, Aitchison T. Is homoeopathy a placebo response? Controlled trial of homoeopathic potency, with pollen in hay fever as a model. Lancet 1986; ii: 881-886.
Taylor MA, Reilly D, Llewellyn-Jones RH, McSharry C, Aitchison T, Lancaster T, Vickers A. Randomised controlled trial of homeopathy versus placebo in perennial allergic rhinitis with overview of four trial series British Medical Journal 2000; 321: 471-476.